Cancer survivors have a higher risk of new primary cancer, in the same or in another organ, than the general population. We report a 78-year-old women who has metachronous quadruple adenocarcinoma ...
In 2020, the University of Cincinnati Medical Centre launched the first ever clinical trial of Flash proton radiotherapy in patients whose primary cancer had metastasised to the bones, with early ...
The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
Bristol Myers Squibb said it is disappointed with the outcome of a study that examined whether one of its drugs could be used to treat a certain type of skin cancer. The drug, Opdualag, didn't meet ...
17d
News Medical on MSNChemotherapy linked to persistent nerve pain in 4 in 10 cancer patientsWorldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...
Molly MacDonald turned adversity into action, founding The Pink Fund to support breast cancer patients. Her journey reveals powerful lessons on resilience and leadership.
Evaluating the clinical benefits of anti-cancer drugs approved by Food and Drug Administration for gastrointestinal neoplasms for the past two decades. This is an ASCO Meeting Abstract from the 2025 ...
Mechanical factors influence the initial fate of cancer cells after they have left a primary tumour. Blood-flow patterns from the primary tumour determine which organ the cells travel to first.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results